GTM Strategy
The Prescription Problem
The latest technology isn't always the cure. Sometimes it's simply symptom relief. Sustainable growth doesn't come from masking problems with better tools. It comes from understanding what's actually causing the symptoms, fixing the underlying system, and then using technology to accelerate what already works. Just like medicine, the right treatment starts with the right diagnosis.
By Big Wheel Performance · 2026-06-18
The Prescription Before the Diagnosis
Imagine going to the doctor because you've been feeling exhausted for months. Instead of asking questions, running tests, or trying to understand what's causing the problem, they immediately write a prescription and send you on your way.
No bloodwork. No imaging. No diagnosis.
Most people would find that absurd. Yet companies do something remarkably similar every day.
Growth slows down, forecasts become unreliable, conversion rates decline, and revenue becomes less predictable. The symptoms are real, and they create pressure throughout the organization. Leadership wants answers, boards want confidence, and investors want predictability. In response, companies begin searching for a solution.
Too often, they start with technology.
The Latest Technology Isn't Always the Cure
The market is overflowing with tools that promise to solve growth challenges.
Companies are collectively spending nearly $50 billion annually on sales technology alone, a figure projected to grow fourfold over the next decade. ¹ AI-powered forecasting platforms promise better visibility. Revenue intelligence tools promise better decision-making. Sales automation platforms promise greater efficiency. Conversation analytics promise deeper insights into customer behavior.
Each solution sounds compelling, especially when the business is under pressure.
The assumption is understandable: if we can just get better data, better visibility, or better automation, we'll solve the problem.
But that's the equivalent of prescribing medication before understanding the illness.
And the results reflect it. In a survey of 200 U.S. finance chiefs, only 14% reported seeing a clear, measurable impact from their technology investments. ² The technology may be effective. It may even be best-in-class. The issue is that nobody has confirmed what problem it's actually supposed to solve.
The Symptoms Aren't the Disease
One of the most common patterns we see is companies treating symptoms as if they are root causes.
A forecasting problem gets labeled as a visibility problem, so they invest in forecasting software. A pipeline problem gets labeled as a lead generation problem, so they invest in more top-of-funnel activity. A conversion problem gets labeled as a sales productivity problem, so they add new sales enablement tools.
Sometimes these investments create temporary improvement. More often, they create the appearance of progress without addressing what's actually driving the outcome.
Because underneath the missed forecast may be inconsistent qualification standards. Beneath poor pipeline conversion may be an ICP that's too broad. Behind unreliable CRM reporting may be sales stages that mean something different to every rep.
The visible symptom gets attention. The underlying condition remains untreated.
Technology Doesn't Fix the System
The uncomfortable reality is that technology doesn't create discipline, process, or alignment.
It amplifies whatever already exists.
If qualification is inconsistent, technology scales inconsistency. If CRM data is unreliable, technology helps you analyze unreliable information faster. If forecasting is built on subjective judgment rather than objective criteria, technology simply produces more sophisticated versions of the same flawed forecast.
The numbers bear this out. Research shows that 55% of CRM implementations fail to achieve their planned objectives. ³ And the root cause is almost never the technology itself, where over 60% of those failures trace back to people and process challenges, not technical problems with the software. ⁴
The tools aren't failing.
They're reflecting the condition of the system they're operating within.
This is why so many organizations invest heavily in new platforms only to find themselves having the same conversations six months later. The dashboards look different. The reports are more advanced. But the outcomes haven't fundamentally changed.
The Diagnostic Work Most Companies Skip
Before a physician recommends treatment, they focus on understanding the cause. They gather evidence, look for patterns, and identify the source of the problem before deciding how to solve it.
Revenue organizations need the same discipline.
Before investing in another platform, companies should understand whether their ICP is clearly defined, whether their messaging consistently resonates with buyers, whether opportunities are being qualified the same way across the team, and whether pipeline stages actually reflect buying progression.
They should know whether they can trust the data in their CRM and whether their forecasts are based on objective criteria or individual interpretation.
These are the diagnostic tests of a go-to-market organization.
Without them, every solution is simply an educated guess.
The Best Technology Strategy
The highest-performing companies aren't anti-technology. In fact, they're often aggressive adopters of new tools.
The difference is that they diagnose first.
They establish clear processes, align teams around common definitions, create consistency in how revenue is measured, and build operational discipline into the system. Once that foundation is in place, technology becomes incredibly powerful — because it's accelerating a healthy process instead of compensating for a broken one.
That's when forecasting tools improve forecasting. That's when AI enhances decision-making. That's when automation actually creates efficiency.
The technology works because the underlying system works.
The Bottom Line
The latest technology isn't always the cure. Sometimes it's simply symptom relief.
Sustainable growth doesn't come from masking problems with better tools. It comes from understanding what's actually causing the symptoms, fixing the underlying system, and then using technology to accelerate what already works.
Just like medicine, the right treatment starts with the right diagnosis.
Key Takeaways
Technology doesn't fix broken processes - it amplifies them.
55% of CRM implementations fail to achieve their objectives, and more than 60% of those failures are process and people problems, not software problems.
Companies that scale diagnose their revenue system before investing in new tools.
The highest-performing organizations use technology to accelerate a healthy system, not compensate for a broken one.
Sources
Sales Tech Market Size, Share | CAGR of 17.1% — Market.us (https://market.us/report/sales-tech-market/)
So Far, Few CFOs See Substantial ROI From AI Spending — CFO.com (https://www.cfo.com/news/so-far-few-cfos-see-substantial-roi-from-ai-spending-RPG/808249/)
The CRM Failure Rate is 55% — Johnny Grow (https://johnnygrow.com/crm/the-crm-failure-rate-is-55-percent/)
Why 70% of CRM Projects Fail — VantagePoint (https://vantagepoint.io/blog/hs/why-70-of-crm-projects-fail-and-how-the-people-process-technology-framework-prevents-it/)
Built to Scale, Scale to Win.
#RevenueOperations #RevOps #GTMStrategy #GoToMarket #B2BSales #SalesProcess #SalesTechnology #TechStack #RevenueGrowth #SalesLeadership #RevenueSystem #SalesStrategy #ICP #RevenueArchitecture #ScalingRevenue #SalesExecution #BigWheelPerformance